With the technology advances we have seen in the last 10 years, it’s hard to believe that, only 50% of clinical trials are using Electronic Data Capture (EDC), whilst the other 50% are still being run on paper and in Excel spreadsheets.
Why is this adoption rate so low? The answer lies in the cost and complexity perspectives of switching to EDC. Barriers that existed in the past could generally be navigated by large pharma companies that had the money and manpower to overcome them. For startup companies, it was a different story.
The situation has now changed, and the reality is that it is almost always cheaper to capture data electronically.
Lower costs, greater ease of use
Costs are the first factor that will help the industry get to the 99% acceptance rate. In the past, if you purchased a cheap system, you generally found yourself lacking in features. The advent of online solutions and cloud capabilities has changed all that.
EDC softwares with the same capabilities as the most expensive systems have seen their price decrease dramatically.